Luca Grumolato

4PUBLICATIONS
21CO-AUTHORS
Molecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Aug 22, 2025
Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells.

Lisa Brunet, David Alexandre, Jiyoung Lee

|Jan 21, 2023
Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer.

Houssein Chhouri, David Alexandre, Luca Grumolato

|Nov 26, 2021
High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer.

Anita Rogic, Ila Pant, Luca Grumolato

|Dec 09, 2020
Tolerant/Persister Cancer Cells and the Path to Resistance to Targeted Therapy.

Mirna Swayden, Houssein Chhouri, Youssef Anouar

Pageof 1

Frequent Collaborators

2 joint publications

Stuart A Aaronson

1 joint publications

Anita Rogic

1 joint publications

Ila Pant

1 joint publications

Ruben Fernandez-Rodriguez

1 joint publications

Aaron Sun

1 joint publications

Shabnam Jaffer

1 joint publications

Guray Akturk

1 joint publications

Rosa Karlic

1 joint publications

Mihaela Skobe

1 joint publications

David Alexandre

Frequent Collaborators

2 joint publications

Stuart A Aaronson

1 joint publications

Anita Rogic

1 joint publications

Ila Pant

1 joint publications

Ruben Fernandez-Rodriguez

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

8.9K
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on : Jul 03, 2025

353
See more related videos

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

8.9K
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on : Jul 03, 2025

353
See more related videos